Fremont-based
Shockwave Medical, which is developing treatments for calcified cardiovascular disease, has raised $45M in a Series C funding round. The funding was led by Sectoral Asset Management, and also included T. Rowe Price Associates, Sofinnova Partners, Venrock, RA Capital, Deerfield, Ally Bridge Group and others. Shockwave Medical's CEO and co-founder is Daniel Hawkins. The company said the funding will be used to advance its balloon catheter platform into new therapeutics areas, and to expand commercialization of its technology.
posted on Tuesday, November 22, 2016 (Link to more information)
Related companies:
ShockWave Medical, Inc.
Related stories:
> Shockwave Medical Finds $35M For Cardiovascular Therapy
> Viacom's MTV Buys Atom Entertainment
> Vertos Medical Raises $12M
> Genome Medical Gains $23M
> Kona Medical Gets $10M
silicontap.com Home